MAYO CLINIC PROCEEDINGS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2023-11-25 osmataku 来自北京

《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2022-04-28 taiggll

审稿速度:1.0
经验分享：太慢了，first decesion需要三个多礼拜

94 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2022-01-09 ms6000001712140296

可以投个案报道吗？

95 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2020-03-10 mantou9524

投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献

190 0

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2019-12-11 budongchishi

请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表:
偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。

muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。

206 0

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2019-12-11 budongchishi

请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表:
官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review

139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review

272 0

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2018-12-06 麦迪斯

你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表::
官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表:
官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review

139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review

262 0

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2018-05-16 1ddccb01m45(暂无匿称)

官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review

316 0

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2017-07-16 13805560183

赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦

390 0

[GetPortalCommentsPageByObjectIdResponse(id=2170910, encodeId=8be221e091067, content=《梅奥诊所学报》是普通科和内科领域首屈一指的在线同行评审临床期刊之一，是医生阅读最广泛、引用率最高的科学出版物之一。虽然该会议记录由梅奥诊所赞助，但它欢迎世界各地的作者提交意见，发表专注于临床医学并支持读者的专业和教育需求的文章。《梅奥诊所学报》自 1926 年以来持续出版，内容包括获得诺贝尔奖的研究。《Proceedings》的影响因子为 8.9，在医学、综合和内科类别的 167 种期刊中排名第 20。梅奥诊所是美国最大的非营利性学术医疗系统之一，年收入达 140 亿美元，拥有 65,000 名员工。 Mayo Clinic 专注于治疗患有严重、复杂疾病的患者，在五个州开展业务，每年为来自所有 50 个州和近 140 个国家的超过 100 万人提供护理。梅奥诊所被《美国新闻与世界报道》评为全美第一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Nov 25 12:14:53 CST 2023, time=2023-11-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1215333, encodeId=42aa121533363, content=审稿速度:1.0 经验分享：太慢了，first decesion需要三个多礼拜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLCCeThUkLSpe1ZIh7hdMUD7d5RwscibglhyEuzkj7D5gg3h60uFByCCxc7GkicCCsTfIoIgWu3xVKgw/132, createdBy=e54e5193584, createdName=taiggll, createdTime=Thu Apr 28 15:26:51 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182563, encodeId=ac921182563ff, content=可以投个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba755495375, createdName=ms6000001712140296, createdTime=Sun Jan 09 16:48:09 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586331, encodeId=45e35863310d, content=投稿一周就被拒了，投稿时需要每一位作者登录邮箱确认作者贡献, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qyanRmH7Xoib1bkwI76vQoHAYSDskBPAP2G1iaJicb7NIWTHkibffwN292w9868QOuZicdtwGY6OYeic8dUX1gl2DA5Q/132, createdBy=8cb75250711, createdName=mantou9524, createdTime=Tue Mar 10 21:14:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581288, encodeId=2af6581288fd, content=请问下是每个作者的邮箱都要点进去确认吗？muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=muluwen123 2016-11-24 15:43:00 发表: 偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581289, encodeId=16e158128934, content=请问下是需要所有作者都邮箱确认吗？139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ2nd0H9DVmzvGIqfMUibOzQHviaEoiaP9o4p4kdA5yQDjtGTMffa97XmrwcIkOWDn6otnpBR6ImWoQw/132, createdBy=7d371936204, createdName=budongchishi, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564130, encodeId=bed256413011, content=你好，请问你的文章状态里是不是有Awaiting forms completion一项？我的显示under review两个多月了，不知道是不是表格没有提交成功。139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review139****0345(暂无匿称) 2018-05-16 07:43:00 发表: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=139****0345(暂无匿称) 2018-05-16 发表:: 官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DdjEyZuwOYAPib0x0GFvoFzIFcN6Ahz4LPB7tqNfZvIuFVr1eiaPzg7w84Zfic7ABIUscPZQ6QL8mBHYg9AI2jvUQ/132, createdBy=cb892435088, createdName=麦迪斯, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556087, encodeId=fd7255608ef3, content=官网上说投稿后1-2周内副编辑评估文章质量决定是否外审.我的文章是投稿后7个工作日.投稿状态由associate editor checklist转变为 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed May 16 07:43:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544315, encodeId=c42a54431579, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=390, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529745, encodeId=1d8c529e45a6, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb21613107, createdName=muluwen123, createdTime=Thu Nov 24 15:43:00 CST 2016, time=2016-11-24, status=1, ipAttribution=)]

2016-11-24 muluwen123

审稿速度:1.0 | 投稿命中率:5.0
经验分享：偏爱肿瘤内科前瞻性临床研究数据，投了一篇肝癌介入治疗文章，从邮箱确认完毕至收到拒稿信不到6小时。

348 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务